Medtronic Says Study Data Published on Stent in Diabetes Patients

The current issue of JACC: Cardiovascular Interventions, a peer-reviewed journal published by the American College of Cardiology, includes an article that describes how the Resolute Integrity drug-eluting stent from Medtronic, Inc. (NYSE: MDT ) became the first and only device of its kind to be approved by the U.S. Food and Drug Administration (FDA)